The frequency of FLT3-ITD and FLT3-TKD mutations was nearly identical in the short-lived subgroup and an additional stratification according to the specific type of FLT3 mutation did not further improve our classification of DNMT3A-mutant AML patients from TCGA. This evidence concerns the gene DNMT3A and acute myeloid leukemia.